Education
About Us
Working with TipRanks
Follow Us
Aspen Pharmacare (APNHY)
OTHER OTC:APNHY
Earnings Data
Report Date
Sep 03, 2025TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
―Last Year’s EPS
0.25Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
Aspen's earnings call highlighted significant achievements, particularly in revenue and EBITDA growth, successful acquisitions, and promising opportunities in the GLP-1 market. However, challenges such as currency impacts, difficulties in China, and increased tax and working capital levels posed notable concerns.Company Guidance -
Q4 2025
Strong Revenue Growth
Aspen reported a 9% revenue growth at constant exchange rates (CER) and 4% in reported terms, highlighting a robust performance despite currency fluctuations.
Normalized EBITDA Surge
Normalized EBITDA increased by 21% at CER and 12% in reported terms, significantly outpacing revenue growth and demonstrating strong operational efficiency.
Commercial Pharma Performance
The Commercial Pharma segment achieved double-digit growth with revenue and EBITDA both increasing. The segment is derisked from major market headwinds, such as China VBP and Russia.
Successful LatAm Acquisition
The acquisition in Latin America was executed seamlessly, achieving over 100% of expected sales, marking a significant milestone for Aspen in the region.
GLP-1 Opportunity
Aspen is well-positioned in the GLP-1 market, with submissions underway and positive feedback from stringent regulators, marking a transformative opportunity for the company.
Sustainability Initiatives
Aspen outlined ambitious sustainability goals, including reducing carbon emissions by 50% by 2030 and achieving gender balance in top management.
APNHY Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
APNHY Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 03, 2025 | $8.79 | $9.82 | +11.72% |
Oct 02, 2024 | $11.23 | $11.26 | +0.27% |
Mar 04, 2024 | $10.18 | $10.60 | +4.13% |
Aug 30, 2023 | $9.81 | $9.01 | -8.15% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Aspen Pharmacare (APNHY) report earnings?
Aspen Pharmacare (APNHY) is schdueled to report earning on Sep 03, 2025, TBA (Confirmed).
What is Aspen Pharmacare (APNHY) earnings time?
Aspen Pharmacare (APNHY) earnings time is at Sep 03, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is APNHY EPS forecast?
Currently, no data Available